Cirio Advokatbyrå AB houses a broad offering known for its strength in tech-focused life sciences issues, particularly in relation to digital health. Per Hedman leads the ‘very diligent’ team with his deep knowledge of the medtech industry, often assisting with high-value transactional mandates ranging from M&A to licensing and collaboration agreements. Hedman routinely acts for investment entities and both domestic and international biotech and medtech clients. Data protection expert Hanna Tilus is a key contact for all matters concerning tech transfers, major patent litigation, and co-marketing issues. Odd Swarting contributes his longstanding experience in M&A, joint ventures, and financing issues.
Legal 500 redaktioneller Kommentar
- Profil
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘The team at Cirio is very diligent and puts a lot of effort into finding solutions fit for purpose. Always reliable.’
‘Hanna Tilus is very diligent and always put a lot of effort into finding solutions that are appropriate for us in a given situation.’
‘Hanna Tilus is a trusted adviser. Honest, pragmatic and business minded.’
‘The team is efficient, delivers hands-on legal advice and are easy-going to work with. I believe the Cirio team has unique strength in the Swedish market thanks to Hanna Tilus, who can combine her expertise within pharmaceuticals and data protection - it is an edge that few other Swedish firms can offer.’
Kernmandanten
- Takeda
- 10x Genomics
- Recipharm
- Boule Diagnostics
- Hadean Ventures
- Karolinska Development
- Intervacc
- Scandinavian Biopharma
- Sprint Bioscience
- Abliva
Highlight-Mandate
- Advised Abliva on a licensing and collaboration agreement with US-based Owl Therapeutics concerning Abliva’s NeuroSTAT for the treatment of moderate to severe traumatic brain injury.
- Advised FrostPharma (controlled by private equity firm Priveq) on its acquisition of Abboxia creating one of the leading specialty pharma companies in the Nordics with a wide product portfolio of hospital pharmaceuticals.
- Advised Anocca in relation to its clinical trial of its highly specialised TCR-T cancer therapy 2 involving negotiation of master service agreement with CRO, agreements with other service providers and providing regulatory advice.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Partner*innen der nächsten Generation
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Praxisleitung
Per Hedman
Weitere Kernanwält*innen
Odd Swarting; Hanna Tilus